Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-12-18 5:25 pm Sale |
2023-12-14 | 13D | Seagen Inc. SGEN |
Baker Bros. Advisors LP | 0 0.000% |
-45,074,469 (Position Closed) |
Filing History |
| 2023-06-09 3:48 pm Sale |
2023-06-12 | 13G | Seagen Inc. SGEN |
Capital International Investors | 7,227,865 3.900% |
-10,830,216 (-59.97%) |
Filing History |
| 2023-05-03 4:15 pm Purchase |
2023-05-01 | 13D | Seagen Inc. SGEN |
Baker Bros. Advisors LP | 45,074,469 24.000% |
45,074,469 (New Position) |
Filing History |
| 2023-03-13 4:30 pm Purchase |
2023-03-12 | 13D | Seagen Inc. SGEN |
Baker Bros. Advisors LP | 47,233,651 25.300% |
10,043 (+0.02%) |
Filing History |
| 2023-02-13 3:54 pm Purchase |
2023-02-14 | 13G | Seagen Inc. SGEN |
Capital International Investors | 18,058,081 9.700% |
5,279,652 (+41.32%) |
Filing History |
| 2023-02-10 4:20 pm Unchanged |
2022-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
SEATTLE GENETICS INC SGEN |
46,327 5.000% |
0 (Unchanged) |
Filing History |
| 2023-02-09 11:32 am Purchase |
2022-12-30 | 13G | Seagen Inc. SGEN |
The Vanguard Group | 12,945,078 6.970% |
805,039 (+6.63%) |
Filing History |
| 2023-02-06 2:58 pm Sale |
2022-12-30 | 13G | Seagen Inc. SGEN |
WELLINGTON MANAGEMENT CO LLP | 9,881,292 5.320% |
-1,748,437 (-15.03%) |
Filing History |
| 2023-01-31 5:52 pm Sale |
2022-12-31 | 13G | Seagen Inc. SGEN |
BLACKROCK INC BLK |
11,861,464 6.400% |
-1,480,289 (-11.10%) |
Filing History |
| 2022-03-10 4:40 pm Sale |
2022-03-08 | 13D | Seagen Inc. SGEN |
Baker Bros. Advisors LP | 47,223,608 25.700% |
-394,895 (-0.83%) |
Filing History |
| 2022-02-11 11:19 am Sale |
2022-02-14 | 13G | Seagen Inc. SGEN |
Capital International Investors | 12,778,429 7.000% |
-7,094,465 (-35.70%) |
Filing History |
| 2022-02-10 08:37 am Purchase |
2021-12-31 | 13G | Seagen Inc. SGEN |
The Vanguard Group | 12,140,039 6.640% |
254,756 (+2.14%) |
Filing History |
| 2022-02-04 09:22 am Purchase |
2021-12-31 | 13G | Seagen Inc. SGEN |
WELLINGTON MANAGEMENT CO LLP | 11,629,729 6.360% |
11,629,729 (New Position) |
Filing History |
| 2022-02-01 5:08 pm Purchase |
2021-12-31 | 13G | Seagen Inc. SGEN |
BLACKROCK INC BLK |
13,341,753 7.300% |
821,674 (+6.56%) |
Filing History |
| 2021-05-18 4:41 pm Purchase |
2021-05-14 | 13D | Seagen Inc. SGEN |
Baker Bros. Advisors LP | 47,618,503 26.200% |
3,226 (+0.01%) |
Filing History |
| 2021-04-02 4:20 pm Purchase |
2021-03-24 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
SEATTLE GENETICS INC SGEN |
46,327 6.200% |
46,327 (New Position) |
Filing History |
| 2021-02-16 4:04 pm Unchanged |
2021-02-16 | 13G | Seagen Inc. SGEN |
Capital International Investors | 19,872,894 11.000% |
0 (Unchanged) |
Filing History |
| 2021-02-16 2:24 pm Purchase |
2021-02-16 | 13G | Seagen Inc. SGEN |
Capital International Investors | 19,872,894 11.000% |
19,872,894 (New Position) |
Filing History |
| 2021-02-16 12:23 pm Purchase |
2020-12-31 | 13G | Seagen Inc. SGEN |
PRICE T ROWE ASSOCIATES INC | 7,526,240 4.100% |
7,526,240 (New Position) |
Filing History |
| 2021-02-10 11:52 am Purchase |
2020-12-31 | 13G | Seagen Inc. SGEN |
The Vanguard Group | 11,885,283 6.590% |
11,885,283 (New Position) |
Filing History |